Osteoarthritis 2020 Global Market Key Players, Analysis and Forecast to 2023

 An expert on premium research reports, Market Research Future has added a report titled "Global Osteoarthritis Market 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Osteoarthritis is leads to the breakage of the joint cartilage and is one of the most common forms of arthritis. Osteoarthritis can cause immense pain, swelling, and a limited motion in affected joints. Usually, hands, knees, hips and the spine are highly probable to be affected by osteoarthritis. As per the report by Market Research Future (MRFR), the global osteoarthritis market is expected to ascend at a 6.8% CAGR through the forecast period.

Also Read : https://www.medgadget.com/2019/08/osteoarthritis-market-2019-size-trends-potential-growth-share-and-key-country-analysis-with-forecast-to-2023.html 

Some factors, as mentioned in the latest report by Market Research Future (MRFR) contributing to the ascension of the global osteoarthritis market include a rising prevalence of the geriatric population across the globe. Further, unhealthy lifestyle has led to a proliferation in the number of overweight individuals, magnifying the risk of osteoarthritis among consumers. An improvement in detection techniques has led to a rise in detection rates, driving the global osteoarthritis market. Other than that, improved accessibility to healthcare facilities has also contributed to the global osteoarthritis market growth by 2023.

Key Players for Global Osteoarthritis Market

The report has mentioned various players in the global osteoarthritis market including Abbott. (U.S.), Novartis AG (Europe), Pfizer Inc. (U.S.), Eli Lilly and Company (U.S.), ABIOGEN PHARMA S.p.A (Europe), Merck Sharp & Dohme Corp. (U.S.), TissueGene Inc. (U.S.), Ampio Pharmaceuticals Inc. (U.S.), Regeneron (U.S.).

Industry Update

June 2019: A treatment developed by biomedical engineers in the Cornell University uses a synthetic version of a joint lubricant to bind the surface of cartilage in joints. It acts as a cushion during heavy activities such as running. This treatment is currently in canine clinical trials and will be eventually used in humans.

March 2019: Researchers from the Kennedy Institute of Rheumatology at the University of Oxford, and Jenner Institute have collaboratively developed a vaccine that could be used to treat chronic pain caused by osteoarthritis. The virus-like particle vaccine is capable of triggering the immune system to produce antibodies which would help to block naturally-occurring NGF and alleviate osteoarthritis pain.

Segmental Analysis

The global osteoarthritis market is studied for various segments based on type, diagnosis, treatment, end-users, and region. Based on type, the global osteoarthritis market is segmented into hip osteoarthritis, wrist osteoarthritis, and spinal osteoarthritis. Based on end-user, the osteoarthritis market is segmented into research organization, medical institutes, and hospitals & clinics.

Based on diagnosis, the global osteoarthritis market is segmented into imaging, and joint fluid analysis. Among these segments, the imaging segment is further sub-segmented into X-rays, and magnetic resonance imaging (MRI).

Based on treatment, the osteoarthritis market is segmented into medication, surgery, and therapy. The medication segment is further sub-segmented into non-steroidal anti-inflammatory drugs and analgenics. The analgenics segment is further segmented into acetaminophen and duloxetine. The non-steroidal anti-inflammatory drugs segment is further sub-segmented into ibuprofen, aspirin, naproxen, and naproxen sodium.

Regional Analysis of Global Osteoarthritis Market

The global osteoarthritis market is segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. Among these segments, the Americas are expected to spearhead the global osteoarthritis market over the forecast period. This market domination can be owed to a well-developed healthcare sector and a massive patient population residing in the region. Additionally, changing lifestyle and an increasing healthcare expenditure have also contributed to the ascension of the regional osteoarthritis market.  In 2015, a report by the Centre for Disease Control and Prevention, 17.8% of US’s total GDP accounted for the country’s healthcare expenditure, which came to USD 3.2 trillion.

Europe, on the other hand is anticipated to follow the Americas and owe for the second largest osteoarthritis market during the forecast period. Such market growth can be attributed to the rising availability of funds for research and a huge patient population for osteoarthritis. Further, increasing healthcare expenditure in the region, along with a well-developed healthcare sector and government support for R&D projects are boosting growth in the regional osteoarthritis market over the review period. Western Europe is anticipated to hold the largest share in the regional osteoarthritis market with Germany, France, and the UK at the forefront. However, Eastern Europe is estimated to grow at a relatively faster rate owing to expansion opportunities for various market players.

Asia Pacific is anticipated to grow at the fastest rate during the forecast period, owing to the presence of a massive patient population and the presence of significant developing countries such as China and India. Further, humongous growth opportunities for various international and regional market players are expected to drive the market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/osteoarthritis-market-1609

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Pharmacogenomics Market | Worldwide Top key Players Profile Analysis | Forecast till 2023

 This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Pharmacogenomics Market over the forecast period.

Pharmacogenomics Market: Segmental Analysis

The global market for pharmacogenomics has been segmented on the basis of technology, application, and end user.

The types of technology in the market include microarray, sequencing, polymerase chain reaction, and others. The sequencing segment is further segmented on the basis of Sanger sequencing, pyrosequencing, next-generation sequencing, and others.

Also Read : https://www.medgadget.com/2019/11/pharmacogenomics-market-2019-by-size-share-latest-innovation-industry-trends-growth-factors-demands-opportunities-key-players-analysis-forecast-2023.html 

The segments based on application are oncology, cardiology, neurological disorders, and others. The oncology segment can be considered for breast cancer, lung cancer, and others.

On the basis of end users, the market is segmented into hospitals, research organizations, academic institute, and others.

Market Drivers and Top Barriers

According to Market Research Future (MRFR), the Global pharmacogenomics market is projected to expand at a CAGR of 5.8% over the forecast period (2017-2023).

The deciding factors in the pharmacogenomics market growth include the surging expenditure in research and development (R&D) along with the elevating rate of adverse reactions. World over, there has been a rising focus on precision medicine coupled with the growing need for drug safety as well as efficacy, which has led to the market expansion in recent years.

On that note, the strong focus on precision medicine is striving to expand the pharmacogenomics market, as the primary aim of precision medicine is integrating genetic as well as environmental information of certain diseases along with their responses to specific treatments. This factor helps in targeted drug therapies, in addition to the growing adoption of treatment procedures that reduce the side effects and achieve accurate results, which makes extensive use of pharmacogenomics. For instance, in 2015, the United States (U.S.) government had implemented a new precision medicine initiative to augment the development of individualized care, which includes genetic variability for a variety of chronic disorders.

Additionally, the rapid growth in the number of research studies associated with sequencing, particularly next-generation sequencing, will raise the demand for pharmacogenomic tests in the years to come. This factor will play an integral role in market growth to a large extent.

Market Opportunities

Pharmacogenomics is considered to be a vital aspect in terms of cancer treatment, having proved to be a favorable option helping with the survival of patients. Over and above that, pharmacogenomics also has managed to reduce the additional cost owing to unresponsive treatment. Therefore, growing use of pharmacogenomics for the treatment of cancer has resulted in numerous significant discoveries, which is bound to contribute to the growth of the worldwide market in the upcoming period.

Pharmacogenomics Market: Competitive Analysis

• Assurex Health Inc. (U.S.),
• Pathway Genomics (U.S.),
• Teva Pharmaceutical Industries Ltd. (Israel),
• Myriad Genetics, Inc. (U.S.),
• GeneDx. (U.S.),
• Future Science Group (U.S.),
• GeneTech (U.S.),
• 23andMe, Inc. (U.S.)

Pharmacogenomics Market: Latest Industry Updates

May 2019: Premier Health Group has partnered with Navigator Genomics (NGT), in a bid to offer access to their Pharmacogenomic Testing. This testing will be for medical cannabis along with 416 of the popular medicines. This will ensure that the patients are provided with the best medical drugs, avoiding the medication that are not effective.

October 31, 2018: The U.S. Food and Drug Administration has recently announced that they have approved the marketing of 23andMe’s reports on pharmacogenetics. The genetic-testing company claims are designed to assess whether the genetics will affect an individual’s ability to metabolize certain drugs which include antidepressants.

Nov 2017: Myriad Genetics, Inc., announced positive results from a double-blind, multi-center, randomized controlled trial assessing the impact of the GeneSight Psychotropic test (GeneSight) on psychiatric treatment response in 1,200 patients with major depressive disorder. GeneSight is one of the leading pharmacogenomics test to help guide medication selection for mental health disorders.

Pharmacogenomics Market: Regional Analysis 

The pharmacogenomics market is spread across the primary regions of the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas has been identified as the dominant region in the global pharmacogenomics market, on account of highly-developed healthcare industry coupled with the inclusion of developed countries such as the United States (U.S.) as well as Canada. Furthermore, the expansion of the patient pool suffering from cardiovascular diseases as well as the growing healthcare expenditure is nurturing the growth of the regional market. As per the Centers for Diseases Control and Prevention, in 2015, heart disease had been the main cause of death for men as well as women in the U.S. In addition, the analysis suggested that the spending on healthcare for heart diseases in the country touches the valuation of USD 200 billion every year.

Data analysts concur that Europe stands second in the global pharmacogenomics market, with the Asia Pacific following suit. The surge in the funds for research and development on top of the increasing government support and the expanding patient population will prove to be instrumental in the market growth. Plus, the region also benefits from the primary contribution of the developed nations such as France and Germany with excellent growth prospects in the medical field.

Racing ahead at the fastest growth rate is the region of Asia Pacific, with the primary reasons being the burgeoning patient pool and the progressively growing economies such as India and China in the region. The Indian Brand Equity Foundation had reported in 2016 that the biotech industry in India is expected to arrive at the valuation of USD 100 billion by the year 2025, crossing the value of USD 7 billion it had reached in 2015. The industry is also expected to expand at a growth rate of 30.46% in the mentioned evaluation period, as per reports.

Meanwhile, the growth of the Middle East & Africa market has been inferior to other regions in the global pharmacogenomics market. This stunted growth can be the result of the poor economy, low expenditure on healthcare, and the rigid government policies, particularly in Africa. Concurrently, the substantial portion of the regional market is controlled by the Middle East, with the backing from the well-established healthcare industry combined with the growing healthcare expenditure. Apart from this, developed countries such as Dubai, Saudi Arabia, and Qatar have a big hand in the growth of the Middle East & Africa market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Companion Animal Healthcare Market Poised to Witness a Significant Growth by 2023

 Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Companion Animal Healthcare Market Research Report - Forecast to 2023” Gives industry size, top players and worldwide demand

The Global Companion Animal Healthcare Market is predicted to touch USD 20 billion at a 9.6% CAGR over the forecast period (2017-2023), as per the latest Market Research Future (MRFR) report.

Segmentation – Companion Animal Healthcare Market

The Market Research Future report provides a wide segmental analysis of the companion animal healthcare market based on end users, diagnostic tests, and product.

Also Read : https://www.medgadget.com/2019/11/companion-animal-healthcare-market-2019-share-size-trends-growth-regional-analysis-with-global-industry-forecast-to-2023.html 

Based on product, the companion animal healthcare market is segmented into vaccines, pharmaceuticals, and feed additives. The feed additives segment is again segmented into medicinal feed additives and nutritional feed additives. The nutritional feed additives segment is further segmented into vitamins, minerals, and proteins, and medicinal feed additives are further segmented into probiotics and prebiotics, immune-modulators, enzymes, hormones, and others. The pharmaceutical products segment is further segmented into anti-inflammatories, antibiotics, and anti-infectives. Of these, the pharmaceutical products segment will have the largest share in the market over the forecast period. This is owing to the rising prevalence of food-borne diseases, brucellosis as well as other zoonotic diseases which are hazardous to animals.

Based on diagnostic tests, the companion animal healthcare market is segmented into molecular diagnostics, immunodiagnostic tests, diagnostic imaging, and others. Of these, the diagnostics imaging segment will dominate the market over the forecast period. This is owing to rising zoonotic infections that is boosting the need for establishing point-of-care testing and diagnostics laboratories.

Based on end users, the companion animal healthcare market is segmented into home care, veterinary clinics, and veterinary hospitals. Of these, the veterinary clinics and veterinary hospitals will lead the market over the forecast period. This is owing to the accessibility of a huge variety of diagnostic options.

Market Overview nd Drivers 

Companion animals are used for amusement, company, extrovert display, psychological support, and other functions which humans require for sharing with animals. A yearly veterinary checkup is one of the finest means of keeping the pet healthy.

Various factors are propelling the companion animal healthcare market growth. These factors, as stated by the MRFR report, include growing pet adoption across the world, increasing government initiatives for animal health, growing advancements in technology in animal healthcare, and increasing nuclear families that have accelerated the trend of pet ownership. Additional factors pushing market growth include growing investments made by key players for developing advanced pet care solutions, increasing awareness about animal cruelty, advances in animal vaccines and health medicines, and increased types of medical treatment.

Key Players – Companion Animal Healthcare Market

Leading players profiled in the companion animal healthcare market report include

• Boehringer Ingelheim (Germany),
• Perrigo Company plc (Ireland),
• Vetoquinol S.A. (France),
• Bayer Animal Health (Germany),
• Elanco Animal Health (US),
• Merial (France),
• Virbac Animal Healthcare (France),
• Ceva Animal Healthcare (UK),
• Merck and Co., Inc. (US), 
• Zoetis Animal Healthcare (US),

among others. Key players have acquired several strategies to gain a competitive edge in the market. This include product launch, expansion, partnership, collaboration, and acquisition.

Competitive Analysis – Companion Animal Healthcare Market

Characterized by the presence of several well-established and small players, the global Market of Companion Animal Healthcare appears to be highly competitive and fragmented. International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.  The Market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

However, well established players integrate acquisition, collaboration, partnership, expansion, and product launch to gain competitive advantage in this market.

For instance; innovative Seresto collar by Bayer to protect dogs and cats against diseases transmitted by parasites. These key players offer a broad range of products with a range of treatment options, especially for bacterial infections.

Zoetis Animal Healthcare is one of the global animal healthcare company provides wide range of products for animal care. Moreover, company provides specific products for dogs, cats and horses. For instance, Apoquel, Cerenia, Convenia, Cytopoint, Palladia, Rimadyl are the products for dogs.

Regional Analysis – Companion Animal Healthcare Market

Based on the region, the companion animal healthcare market report covers the latest trends and growth opportunities across the Asia Pacific, Europe, the Americas, and the Middle East and Africa. Of these, the Americas will spearhead the market over the forecast period. This is owing to the availability of a huge variety of animal health products.

The companion animal healthcare market in Europe is predicted to have the second-largest share in the market over the forecast period. This is due to an increase in pet ownership on account of tax benefits offered by the government.

The companion animal healthcare market in the APAC region is predicted to have a positive and steady growth over the forecast period. This is owing to the rising awareness about animal cruelty that has influenced people awareness as well as ideologies towards animals.

The companion animal healthcare market in the Middle East and Africa is predicted to have a steady growth over the forecast period. This is owing to high growth opportunities on account of financial improvement and an associated increase in disposable income.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/companion-animal-Healthcare-market-1168 
About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Smart Contact Lenses Market is Growing Massively till 2023

 Market Research Future adds the “Smart Contact Lenses Market Research Report - Forecast to 2023” report to their unique collection.

The Smart Contact Lenses Market to touch the valuation of USD 7.2 billion in 2023, says Market Research Future (MRFR). MRFR also states that the market is slated to achieve a CAGR of 10.4% during the forecast period (2018-2023).

Global Smart Contact Lenses Information, By Application (Continuous Glucose Monitoring, Intraocular Pressure Monitoring), By End User Type (Hospitals, Clinics And Home Care Settings) – Forecast Till 2023

The smart contact lenses market has grown significantly in response to the surging geriatric population and the mounting demand for eye care solutions. The rising adoption of wearable medical devices coupled with the high prevalence of glaucoma and diabetes benefits the market as well. Technological developments in wearable electronics, as well as wireless communication, have turned out to be a vital tool leading to the realization of several medical applications using health monitoring technologies. Smart contact lenses are used to monitor the physiological information of eye as well as tear fluid, providing non-invasive, real-time medical diagnostics.

Also Read : https://www.medgadget.com/2019/09/smart-contact-lenses-market-size-share-analysis-current-dynamics-business-opportunities-trends-growth-of-leader-companies-and-foreseen-by-2023.html 

It is reported that glaucoma affects close to 67 million people around the world and is the main cause of irreversible vision loss and blindness. Smart contact lenses help obtain spontaneous deviations within the eyes and allow the physicians to treat glaucoma backed with essential information. If these reasons are factored in, then the market growth is inevitable during the evaluation period.

Smart contact lenses are considered to be a promising noninvasive solution to monitor glucose. Smart contact lenses with microsensor used for analyzing glucose levels is touted to be life-changing technology within the healthcare sector. Considering various benefits of this technology, the information technology vendors are making moves to capture related technologies in a bid to expand their market presence.

Market Players:

• Sensimed SA (Switzerland),
• Alcon (U.S),
• Sony (Japan),
• Google (U.S),
• Samsung (South Korea),

are the key contributors of the smart contact lenses market.

Industry Update:

July 2019 IMT Atlantique, a French engineering institute, has developed the world’s first micro battery which could work against the challenge of small-scale energy storage during the development of smart contact lenses. This technology has grabbed the attention of the US military and someday could deliver improved visual capabilities along with medical and automotive assistance for them.

March 2018 Theraoptix recently took home the MIT Sloan Healthcare Innovation Prize at their annual competition’s and also received a $25,000 grand prize which was sponsored by Optum, a health services firm. The contact lens is made from FDA-approved materials and delivers eye medication in a sustained and controlled release. The lens is sandwiched between contact lens material which is a drug-filled polymer film and shaped into a tiny circular strip that does not interfere with the wearer’s vision. The sandwiching structure allows the drugs to seep from the film into the eye gradually.

Segments:

The market for smart contact lenses has been segmented on the basis of application and end-users.

The global smart contact lenses market, depending on the application, cover intraocular pressure monitoring, continuous glucose monitoring, and others. Other applications include sodium detection, alcohol detection, and cholesterol detection.

The end users of smart contact lenses are hospitals, clinics, and home care settings.

Regional Analysis:

The main markets for smart contact lenses are Europe, the Americas, Middle East, and Africa and Asia Pacific.

The Americas is considered to be the leading market for smart contact lenses. Huge pool of diabetic population and the surge in demand for eye care solutions with innovative technology have a big hand in the said growth. The rising adoption of sophisticated wearable medical devices, as well as trends in cosmetics, favors the market growth to a great extent. Also, the mounting awareness about fitness along with the availability of wearable medical devices in the region boosts market growth. With the boost in demand for self-monitoring devices, expanding aging population with eye disorders related to diabetes and the user-friendliness of smart contact lenses will do wonders for the regional market growth. The region is also known for developing highly innovative products for eye care as well as diabetes management, which has led to significant market growth over the years.

Europe, as the second leading smart contact lenses market, benefits from the rise in expenditure on research in smart medical devices. The growing use of smart contact lenses in a number of countries bodes well with the market growth in the region. In 2015, the data released by the World Health Organization (WHO) said that more than 60 million people in the region suffered from diabetes. These statistics indicate the rising need for smart contact lenses in the region, resulting in market expansion.

Prevalence of chronic diseases like diabetes and the presence of profitable countries like India and China could lead the Asia Pacific market to greater heights in the next few years. The growing disposable income and the improving economy of the countries in the region are expected to benefit the smart medical devices market.

Middle East and Africa could demonstrate sluggish market growth on account of low technology penetration. There is a rising demand for primary care services in Africa; however the lack of advanced medical care could hold back the region from growing in the near future.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/smart-contact-lenses-market-1186

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Myelodysplastic Syndrome (MDS) Drugs Market is Expected to Exhibit a Strong CAGR during forecast period upto 2023

 The exclusive research report on the Global Myelodysplastic Syndrome (MDS) Drugs Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

Market Highlights

The Global Myelodysplastic Syndrome (MDS) drugs market is expected to grow significantly over the forecast period. The Myelodysplastic Syndrome (MDS) drugs market held a valuation of USD 1,581.59 million in 2018 and is projected to register a CAGR of 10.1% over the forecast period.

Also Read : https://www.medgadget.com/2019/10/myelodysplastic-syndrome-mds-drugs-market-value-analysis-size-2019-share-and-growth-insights-by-bluepoint-laboratories-celgene-corporation-reddys-laboratories-inc-johnson-johnson-etc.html

The increasing participation of key players is one of the key factors driving the Myelodysplastic Syndrome (MDS) drugs market. In 2018, the US Food and Drug Administration approved generic injectable product decitabine for Lupin Ltd. There are various other MDS medications available in the market.

Various other factors that are driving the MDS drugs market are the promotion of clinical studies related to MDS, increasing geriatric population, rise in regulatory approvals, and growing participation of generic drugs manufactures.

However, the risk of infections during blood transfusions and side-effects of chemotherapy may hamper market growth over the forecast period.

Segments – Myelodysplastic Syndrome (MDS) Drugs Market

The global Myelodysplastic Syndrome (MDS) drugs market is segmented based on product, type of syndrome, route of administration, end user, and region.

Based on product, the global Myelodysplastic Syndrome (MDS) drugs market is further segmented into chemotherapy, immunomodulatory drugs, and others. The chemotherapy segment is sub-segmented as conventional drugs and hypomethylating drugs. Hypomethylating drugs include Azacitidine and Decitabine. Conventional drugs comprise Cytarabine, Daunorubicin, and Idarubicin.

The MDS drugs market at a global level is segmented on type of syndrome into refractory cytopenia with multilineage dysplasia, refractory anemia, refractory anemia with excess blasts, refractory anemia with ringed sideroblasts, refractory cytopenia with multilineage dysplasia, and others.

Based on the route of administration, the market is segmented into oral, parenteral, and others. The MDS drugs available in the market are administered through parenteral route, for instance, intravenous or subcutaneous. The parental route has a quick effective after administration. Thus, the parenteral segments have greater growth compared to the other dosage forms in this segment. Based on end user, the market is segmented into hospitals, clinics, ambulatory surgical centers, and others. MDS patients are treated in the hospitals, clinics, and ambulatory surgical centers. MDS drugs are prescribed by physicians to patients, as in critical conditions, it could lead to blood cancer. The hospitals segment holds the major share in this segment as it deals with a larger number of MDS patients compared to clinics and ambulatory surgical centers.

Regional Analysis – Myelodysplastic Syndrome (MDS) Drugs Market

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The global MDS drugs market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European global MDS drugs market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The MDS drugs market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The global Myelodysplastic Syndrome drugs market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key Players – Myelodysplastic Syndrome (MDS) Drugs Market

• BluePoint Laboratories,
• Celgene Corporation,
• Celgene Europe Limited,
• Reddy’s Laboratories, Inc.,
• Johnson & Johnson,
• Lupin Ltd Corporation,
• Otsuka America Pharmaceutical Inc.,
• Sandoz,
• Shilpa Medicare Limited,
• Sun Pharmaceutical Industries Inc.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/myelodysplastic-syndrome-drugs-market-8134 

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Dental Restorative and Regenerative Market is Expected to Exhibit a Strong CAGR during forecast period upto 2023

 An expert on premium research reports, Market Research Future has added a report titled “Global Dental Restorative and Regenerative Material Market 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

The Global Dental Restorative and the Regenerative Material Market are expected to register a CAGR of 6.7% and is anticipated to reach USD 2679.7 Million by 2023. 

Dental restorative and regenerative materials are used to replace damaged or lost teeth, mostly it happens due to dental caries or dental cavities. Simultaneously, dental restorative and regenerative materials are also used in cosmetic dentistry, which improves the appearance of the teeth and enhances the smile of an individual.

Also Read : https://www.medgadget.com/2019/07/2019-dental-restorative-and-regenerative-material-market-expects-an-extensive-growth-at-6-7-cagr-by-3m-biotech-dental-botiss-biomaterials-gmbh-dentsply-sirona-etc.html

The increasing prevalence of dental disorders, availability of identical material, growing dental tourism, rising adherence and biocompatibility, and increasing disposable income are responsible for propelling the market growth. However, the high cost of dental restorative and regenerative material and lack of awareness about dental procedures are hampering the growth of the market.

Key Players

Market Research Future (MRFR) recognizes the following companies as the key players in Dental Restorative and Regenerative Material Market: There are plenty of large and small market players which operate in this market all over the globe.

3M (U.S.), Biotech Dental (Europe), botiss biomaterials GmbH (Europe), Dentsply Sirona. (U.S.), Henry Schein, Inc. (U.S.), Institut Straumann AG (Europe), KaVo Kerr (U.S.), Keystone Dental, Inc. (U.S.), Zimmer Biomet (U.S.) are some of the leading players at the cutting edge of the competition in the market of Dental Restorative and Regenerative Material, globally.

Dental Restorative And Regenerative Material Market Boosters

Dental materials are fabricated materials used in dentistry practices. Dental materials are of different types and they have different characteristics which is related to their intended purpose. There are two major types of dental material, namely, restorative material and regenerative material. Restorative material can resume damaged teeth’s original form and functioning while regenerative material regenerates the damaged parts of the teeth.

Increasing prevalence of dental diseases and trauma majorly drives the market growth during the forecasted period. According to the Oral Health Foundation, from 2010 to 2015 approximately 20% of the children were admitted to the hospitals due to tooth decay or caries. Moreover, according to the American Society for Nutrition in 2016, 47% of the adults in the U.S. had periodontal disease. Additionally, the rising healthcare expenditure, growing dental tourism and rising geriatric population fuels the market growth. However, lack of awareness followed by high cost of products will restrain the market growth.

Key developments

Companies are continuously developing new products to capture the market globally. Thus major players invest more in research and development activity, in order to lead the global market. In this regards, market players undertake various strategic approaches such as acquisitions, partnerships, mergers and new product launch.

Segmentation

The dental restorative and regenerative material market is segmented on the basis of types, end users, and region.

On the basis of types, the market is segmented into restorative material, regenerative material, and others. The restorative material segment is sub segmented into amalgam, resin based composite, glass ionomer, resin modified glass ionomer, porcelain, metal, porcelain-fused-to-metal, others. The regenerative material segment is sub segmented into bone graft materials, membranes, tissue regeneration products, others.

On the basis of end users, the market is segmented into dental research laboratories, dental hospitals and clinics, and others.

Regional Analysis

As compared to other regions, the dental restorative and regenerative material industry in North America contributes largest share. People are more aware and conscious about dental health, which is one of the major factors driving the market. About 17% of children and 27% of adults have untreated dental caries. Major dental restorative and regenerative material manufacturers have a base in this region and they are spending millions in R&D to develop innovative products. Developed medical facilities and availability of skilled dental professional are key factors for the growth for the market. However, factor like high cost of dental treatments is prohibiting the patients from getting dental treatment.

Increasing prevalence of dental diseases in Europe is driving the growth for restorative and regenerative material market, especially in western region of Europe. There are about 345 thousand dentist in Europe. Dentist are now shifting from the use of amalgam and preferring the alternative restoration materials.  Dental diseases carries huge financial burden not only to the individual but also to the society.  Cost of dental treatments is high in Western European countries. Patients from this region are traveling to the other parts of the Europe or world.

 

FOR MORE DETAILS @ https://www.marketresearchfuture.com/reports/dental-regenerative-material-market-4332

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Malocclusion Market is Expected to Experience Immense Growth During upto 2023

 This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Malocclusion Market over the forecast period.

The Global Malocclusion Market is expected to register a CAGR of 7.0%and is anticipated to reach USD 27,720.8 million by 2023. Malocclusion refers to the misalignment of teeth that can lead to serious oral health complications. Malocclusion is most often hereditary, but it can also occur due to other reasons, i.e., childhood habits such as thumb sucking, pacifier use beyond age 3, and others, extra teeth or lost teeth, ill-fitting dental fillings, and jaw tumors.

Also Read : https://www.medgadget.com/2019/06/malocclusion-market-to-showcase-new-innovations-from-leading-players-and-industry-experts-by-2023-planmeca-oy-rocky-mountain-orthodontics-septodont-holding-tp-orthodontics-etc.html 

The increasing prevalence of malocclusion, improvement in the reimbursement scenario, and the rising trend of cosmetic dentistry are the major drivers propelling market growth. However, the lack of technological awareness is expected to constrain the growth of the market.

Segments:

The global malocclusion market is segmented on the basis of class, treatment, and end user.

On the basis of the class, the market is classified into class I, class II, and class III.

On the basis of the treatment, the market is segmented into orthodontic braces, surgery, and others. The orthodontic braces segment is further sub-segmented into metal braces, ceramic braces, clear aligner, and others.

On the basis of the end -users, the market is segmented into the hospital and clinics, dental clinics, and others.

Key Players:

Market Research Future (MRFR) recognizes the following companies as the key players in Malocclusion Market: There are plenty of large and small market players which operate in this market all over the globe.

Some of key the players in the malocclusion market are

• 3M, A-dec Inc.,
• Adenta GmbH,
• Align Technology, Inc,
• American Orthodontics,
• Biolase, Inc.,
• Carestream Health, Inc.,
• Danaher,
• DENTAURUM GmbH & Co. KG,
• Dentsply Sirona,
• G&H Orthodontics,
• Henry Schein, Inc., and 

Midmark Corp., Patterson Companies, Inc., Planmeca OY, Rocky Mountain Orthodontics, Septodont Holding, TP Orthodontics, Inc, Ultradent Products Inc., Zimmer Dental Inc., and others.

Regional Analysis:

The Americas dominate the malocclusion market owing to the improvement in reimbursement scenario, high healthcare expenditure, and the presence of the leading players in the region. According to the American Dental Association, in the United States, Maryland, Utah, Arkansas, and Massachusetts have the highest Medicaid FFS reimbursement rates i.e. 79.3%, 75.3%, 75.2%, and 74.1% respectively, whereas, Wisconsin, California, Washington, Maine, and Iowa have the lowest coverage relative to private dental insurance reimbursement rates.

Europe holds the second position in the malocclusion market. It is expected that the support provided by the government bodies for research & development, increasing healthcare expenditure, and rising prevalence of malocclusion are propelling the growth of the malocclusion market in the European region. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion and then United Kingdom with EUR 223 billion.

Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology and the presence of huge patient pool drive the growth of this market in Asia Pacific region.

The Middle East and Africa hold the least share of the malocclusion market owing to the presence of poor and slow developing countries, especially, in the African region.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/malocclusion-market-5094

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com